BioTelemetry, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 35 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-11-01: Reporting owner RUBIN ROBERT J.; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-11-01: Reporting owner Ferola Peter; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-10-01: Reporting owner GORMAN KIRK E; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-09-28: Reporting owner Broadway Fred; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-11-01 | RUBIN ROBERT J. Director | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,489 0 owned after | $17.67 exercise price | 2018-11-05 | |
| 2018-11-01 | Ferola Peter Officer (SVP & General Counsel) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −75,000 0 owned after | $4.38 exercise price | 2018-11-05 | |
| 2018-10-01 | GORMAN KIRK E Director | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −625 0 owned after | $21.98 exercise price | 2018-10-02 | |
| 2018-09-28 | Broadway Fred Officer (President BioTel Heart) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −39,238 0 owned after | $4.67 exercise price | 2018-10-02 | |
| 2018-09-28 | Broadway Fred Officer (President BioTel Heart) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −26,963 0 owned after | $2.80 exercise price | 2018-10-02 | |
| 2018-09-28 | Broadway Fred Officer (President BioTel Heart) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −23,912 0 owned after | $2.54 exercise price | 2018-10-02 | |
| 2018-09-17 | GORMAN KIRK E Director | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −625 625 owned after | $21.98 exercise price | 2018-09-19 | |
| 2018-08-31 | Wisniewski Daniel Officer (SVP, Technical Operations) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −31,000 29,000 owned after | $4.24 exercise price | 2018-09-05 | |
| 2018-07-27 | Capper Joseph H Director, Officer (President & CEO) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −90,846 0 owned after | $6.56 exercise price | 2018-07-30 | |
| 2018-07-26 | Capper Joseph H Director, Officer (President & CEO) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −209,154 90,846 owned after | $6.56 exercise price | 2018-07-30 | |
| 2018-07-23 | GORMAN KIRK E Director | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 0 owned after | $30.98 exercise price | 2018-07-25 | |
| 2018-07-02 | GORMAN KIRK E Director | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 7,500 owned after | $30.98 exercise price | 2018-07-03 | |
| 2018-06-13 | Capper Joseph H Director, Officer (President & CEO) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −65,787 300,000 owned after | $6.56 exercise price | 2018-06-13 | |
| 2018-06-12 | Capper Joseph H Director, Officer (President & CEO) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −79,292 365,787 owned after | $6.56 exercise price | 2018-06-13 | |
| 2018-06-11 | Capper Joseph H Director, Officer (President & CEO) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −54,921 445,079 owned after | $6.56 exercise price | 2018-06-13 | |
| 2018-05-31 | RIMEL REBECCA W Director | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,338 0 owned after | $17.67 exercise price | 2018-06-01 | |
| 2018-05-24 | RUBIN ROBERT J. Director | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 0 owned after | $21.98 exercise price | 2018-05-29 | |
| 2018-05-11 | Ferola Peter Officer (SVP & General Counsel) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −40,984 0 owned after | $2.80 exercise price | 2018-05-14 | |
| 2018-05-11 | Ferola Peter Officer (SVP & General Counsel) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,107 0 owned after | $2.54 exercise price | 2018-05-14 | |
| 2018-05-11 | Ferola Peter Officer (SVP & General Counsel) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,834 6,835 owned after | $8.68 exercise price | 2018-05-14 | |
| 2018-05-07 | Wisniewski Daniel Officer (SVP, Technical Operations) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −40,000 60,000 owned after | $4.24 exercise price | 2018-05-08 | |
| 2018-05-02 | Getz Heather C Officer (Executive VP & CFO) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 0 owned after | $4.67 exercise price | 2018-05-04 | |
| 2018-05-02 | Getz Heather C Officer (Executive VP & CFO) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −21,405 0 owned after | $4.67 exercise price | 2018-05-04 | |
| 2018-04-26 | Getz Heather C Officer (Executive VP & CFO) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −40,000 0 owned after | $17.44 exercise price | 2018-04-27 | |
| 2018-04-26 | Getz Heather C Officer (Executive VP & CFO) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 0 owned after | $6.95 exercise price | 2018-04-27 | |
| 2018-04-26 | Getz Heather C Officer (Executive VP & CFO) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 0 owned after | $6.43 exercise price | 2018-04-27 | |
| 2018-04-26 | Getz Heather C Officer (Executive VP & CFO) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,570 0 owned after | $8.79 exercise price | 2018-04-27 | |
| 2018-03-13 | Broadway Fred Officer (President BioTel Heart) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −40,000 0 owned after | $16.59 exercise price | 2018-03-14 | |
| 2018-03-13 | Broadway Fred Officer (President BioTel Heart) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 0 owned after | $6.95 exercise price | 2018-03-14 | |
| 2018-03-13 | Broadway Fred Officer (President BioTel Heart) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,158 0 owned after | $8.79 exercise price | 2018-03-14 | |
| 2018-02-14 | Getz Heather C Officer (SVP & CFO) | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,991 18,991 owned after | $33.35 exercise price | 2018-02-16 | |
| 2018-02-14 | Capper Joseph H Director, Officer (President & CEO) | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +49,604 49,604 owned after | $33.35 exercise price | 2018-02-16 | |
| 2018-02-14 | Ferola Peter Officer (SVP & General Counsel) | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,414 7,414 owned after | $33.35 exercise price | 2018-02-16 | |
| 2018-02-14 | Wisniewski Daniel Officer (SVP, Operations) | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,620 7,620 owned after | $33.35 exercise price | 2018-02-16 | |
| 2018-02-14 | Broadway Fred Officer (President BioTel Heart) | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,653 8,653 owned after | $33.35 exercise price | 2018-02-16 |